SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 66 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $11,000 | -97.6% | 9,347 | -93.3% | 0.00% | – |
Q4 2021 | $456,000 | +128.0% | 139,754 | +211.5% | 0.00% | – |
Q3 2021 | $200,000 | -37.5% | 44,863 | -23.7% | 0.00% | – |
Q2 2021 | $320,000 | -44.5% | 58,761 | -23.7% | 0.00% | – |
Q1 2021 | $577,000 | +284.7% | 77,044 | +460.6% | 0.00% | – |
Q4 2020 | $150,000 | -10.7% | 13,742 | -27.9% | 0.00% | – |
Q3 2020 | $168,000 | -31.1% | 19,050 | -16.7% | 0.00% | – |
Q2 2020 | $244,000 | +258.8% | 22,877 | +99.1% | 0.00% | – |
Q1 2020 | $68,000 | -72.2% | 11,490 | -67.7% | 0.00% | – |
Q4 2019 | $245,000 | +32.4% | 35,569 | +98.8% | 0.00% | – |
Q3 2019 | $185,000 | -10.6% | 17,889 | -19.9% | 0.00% | – |
Q2 2019 | $207,000 | +204.4% | 22,347 | +200.0% | 0.00% | – |
Q1 2019 | $68,000 | +300.0% | 7,449 | +154.1% | 0.00% | – |
Q4 2018 | $17,000 | -88.7% | 2,931 | -76.7% | 0.00% | – |
Q3 2018 | $150,000 | +733.3% | 12,566 | +600.4% | 0.00% | – |
Q2 2018 | $18,000 | -56.1% | 1,794 | -44.0% | 0.00% | – |
Q1 2018 | $41,000 | +115.8% | 3,205 | +61.5% | 0.00% | – |
Q4 2017 | $19,000 | +280.0% | 1,984 | +411.3% | 0.00% | – |
Q3 2017 | $5,000 | – | 388 | +4750.0% | 0.00% | – |
Q2 2017 | $0 | – | 8 | -66.7% | 0.00% | – |
Q1 2017 | $0 | – | 24 | -25.0% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 32 | -91.4% | 0.00% | – |
Q3 2016 | $5,000 | – | 371 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |